Intellectual Property

Alongside tangible assets like real estate, IP should be the backbone of your balance sheet. Commercialising your R&D is what generates your company cashflows, after all.

But there have traditionally been huge practical challenges to recognising IP as an asset. Large and public companies overcome these issues through acquisitions and mergers.

But both methods are unwieldy and expensive, making it impractical for mid-market and small growth companies.

There are very few cash-rich, mid-market acquisitive businesses that can follow this route to value improvement.

This is why IPA has developed its DNA process. As R&D and valuation experts, we provide companies with the ability to value and recognise their IP as bankable assets on the balance sheet.

Our unique process is supported by the robust terms of the FRS102 accounting standard, ensuring accurate valuations of the assets across their useful lifetime.

The process is fast and effective, with minimal effort from you. Once you provide all the evidential documents for the R&D your company has undertaken to our 100% cyber-secure servers, we take care of the rest.

And at the end of it, you will have the opportunity to capitalise the assets we create for you as the bedrock to your company’s access to finance.

What makes it all better still is that, through our partnerships with capital providers, you will be able to leverage the future cashflows from your IP to fund your growth now.

It all adds up to a process that delivers added balance-sheet value, fresh finance and the peace of mind that your sensitive IP is safely stored in our 100% secure data vaults.